Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 5 of 5 entries
View as:

Safety and Efficacy of ALZT-OP1a as Adjuvant Treatment in Subjects With Post-Ischemic Stroke Cognitive Impairment (PSCI)

Phase: N/A Priority: Normal
NCT ID: NCT03202147 Org: User:
Start: 12/31/23 End: 12/31/24 Due: 12/31/25

Phase 1 Study of ALZT-OP1 Combination Therapy in Normal Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02482324 Org: User:
Start: 06/30/15 End: 07/31/15 Due: 07/31/16

Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02547818 Org: User:
Start: 09/15/15 End: 11/18/20 Due: 11/18/21

Randomized I/II Phase Study of ALZT-OP1 Combination Therapy in Alzheimer's Disease and Normal Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04570644 Org: User:
Start: 08/28/20 End: 01/18/21 Due: 01/18/22

A Safety and Biomarker Study of ALZT-OP1a in Subjects With Mild-Moderate ALS Disease

Phase: N/A Priority: Normal
NCT ID: NCT04428775 Org: User:
Start: 09/08/20 End: 10/01/21 Due: 10/01/22